Medical - Pharmaceuticals
Compare Stocks
2 / 10Stock Comparison
BGMS vs HYFM
Revenue, margins, valuation, and 5-year total return — side by side.
Agricultural - Machinery
BGMS vs HYFM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Pharmaceuticals | Agricultural - Machinery |
| Market Cap | $22K | $5M |
| Revenue (TTM) | $81K | $146M |
| Net Income (TTM) | $-5M | $-65M |
| Gross Margin | 18.5% | 10.2% |
| Operating Margin | -113.2% | -35.8% |
| Total Debt | $0.00 | $170M |
| Cash & Equiv. | $3M | $26M |
Quick Verdict: BGMS vs HYFM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BGMS is the clearest fit if your priority is long-term compounding.
- -83.6% 10Y total return vs HYFM's -99.8%
HYFM carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.91
- Rev growth -16.0%, EPS growth -1.9%, 3Y rev CAGR -26.5%
- Lower volatility, beta 0.91, Low D/E 75.8%, current ratio 2.72x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -16.0% revenue growth vs BGMS's -89.8% | |
| Quality / Margins | -44.5% margin vs BGMS's -67.1% | |
| Stability / Safety | Beta 0.91 vs BGMS's 2.04 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | -75.4% vs BGMS's -83.6% | |
| Efficiency (ROA) | -16.3% ROA vs BGMS's -106.7% |
BGMS vs HYFM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
BGMS vs HYFM — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — BGMS and HYFM each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HYFM is the larger business by revenue, generating $146M annually — 1807.9x BGMS's $81,000. HYFM is the more profitable business, keeping -44.5% of every revenue dollar as net income compared to BGMS's -67.1%. On growth, BGMS holds the edge at +7.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $81,000 | $146M |
| EBITDAEarnings before interest/tax | -$9M | -$23M |
| Net IncomeAfter-tax profit | -$5M | -$65M |
| Free Cash FlowCash after capex | -$6M | -$8M |
| Gross MarginGross profit ÷ Revenue | +18.5% | +10.2% |
| Operating MarginEBIT ÷ Revenue | -113.2% | -35.8% |
| Net MarginNet income ÷ Revenue | -67.1% | -44.5% |
| FCF MarginFCF ÷ Revenue | -75.2% | -5.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.1% | -33.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +99.4% | -22.7% |
Valuation Metrics
HYFM leads this category, winning 2 of 2 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $21,990 | $5M |
| Enterprise ValueMkt cap + debt − cash | -$3M | $148M |
| Trailing P/EPrice ÷ TTM EPS | -0.00x | -0.07x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 0.51x | 0.03x |
| Price / BookPrice ÷ Book value/share | — | 0.02x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
HYFM leads this category, winning 3 of 5 comparable metrics.
Profitability & Efficiency
HYFM delivers a -32.3% return on equity — every $100 of shareholder capital generates $-32 in annual profit, vs $-187 for BGMS. On the Piotroski fundamental quality scale (0–9), HYFM scores 3/9 vs BGMS's 1/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -187.3% | -32.3% |
| ROA (TTM)Return on assets | -106.7% | -16.3% |
| ROICReturn on invested capital | — | -9.6% |
| ROCEReturn on capital employed | — | -12.1% |
| Piotroski ScoreFundamental quality 0–9 | 1 | 3 |
| Debt / EquityFinancial leverage | — | 0.76x |
| Net DebtTotal debt minus cash | -$3M | $143M |
| Cash & Equiv.Liquid assets | $3M | $26M |
| Total DebtShort + long-term debt | $0 | $170M |
| Interest CoverageEBIT ÷ Interest expense | — | -3.77x |
Total Returns (Dividends Reinvested)
BGMS leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BGMS five years ago would be worth $1,637 today (with dividends reinvested), compared to $16 for HYFM. Over the past 12 months, HYFM leads with a -75.4% total return vs BGMS's -83.6%. The 3-year compound annual growth rate (CAGR) favors BGMS at -45.3% vs HYFM's -56.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -30.1% | -35.0% |
| 1-Year ReturnPast 12 months | -83.6% | -75.4% |
| 3-Year ReturnCumulative with dividends | -83.6% | -91.9% |
| 5-Year ReturnCumulative with dividends | -83.6% | -99.8% |
| 10-Year ReturnCumulative with dividends | -83.6% | -99.8% |
| CAGR (3Y)Annualised 3-year return | -45.3% | -56.8% |
Risk & Volatility
HYFM leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
HYFM is the less volatile stock with a 0.91 beta — it tends to amplify market swings less than BGMS's 2.04 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HYFM currently trades 21.8% from its 52-week high vs BGMS's 14.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.04x | 0.91x |
| 52-Week HighHighest price in past year | $6.70 | $4.78 |
| 52-Week LowLowest price in past year | $0.73 | $0.81 |
| % of 52W HighCurrent price vs 52-week peak | +14.7% | +21.8% |
| RSI (14)Momentum oscillator 0–100 | 48.3 | 54.8 |
| Avg Volume (50D)Average daily shares traded | 97K | 41K |
Analyst Outlook
HYFM leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — |
| Price TargetConsensus 12-month target | — | — |
| # AnalystsCovering analysts | — | — |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 0 | 1 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
HYFM leads in 4 of 6 categories (Valuation Metrics, Profitability & Efficiency). BGMS leads in 1 (Total Returns). 1 tied.
BGMS vs HYFM: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is BGMS or HYFM a better buy right now?
For growth investors, Hydrofarm Holdings Group, Inc.
(HYFM) is the stronger pick with -16. 0% revenue growth year-over-year, versus -89. 8% for Bio Green Med Solution, Inc. (BGMS). The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — BGMS or HYFM?
Over the past 5 years, Bio Green Med Solution, Inc.
(BGMS) delivered a total return of -83. 6%, compared to -99. 8% for Hydrofarm Holdings Group, Inc. (HYFM). Over 10 years, the gap is even starker: BGMS returned -83. 6% versus HYFM's -99. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — BGMS or HYFM?
By beta (market sensitivity over 5 years), Hydrofarm Holdings Group, Inc.
(HYFM) is the lower-risk stock at 0. 91β versus Bio Green Med Solution, Inc. 's 2. 04β — meaning BGMS is approximately 123% more volatile than HYFM relative to the S&P 500.
04Which is growing faster — BGMS or HYFM?
By revenue growth (latest reported year), Hydrofarm Holdings Group, Inc.
(HYFM) is pulling ahead at -16. 0% versus -89. 8% for Bio Green Med Solution, Inc. (BGMS). On earnings-per-share growth, the picture is similar: Bio Green Med Solution, Inc. grew EPS 92. 2% year-over-year, compared to -1. 9% for Hydrofarm Holdings Group, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — BGMS or HYFM?
Hydrofarm Holdings Group, Inc.
(HYFM) is the more profitable company, earning -35. 1% net margin versus -260. 7% for Bio Green Med Solution, Inc. — meaning it keeps -35. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HYFM leads at -27. 4% versus -279. 2% for BGMS. At the gross margin level — before operating expenses — BGMS leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — BGMS or HYFM?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is BGMS or HYFM better for a retirement portfolio?
For long-horizon retirement investors, Hydrofarm Holdings Group, Inc.
(HYFM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 91)). Bio Green Med Solution, Inc. (BGMS) carries a higher beta of 2. 04 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HYFM: -99. 8%, BGMS: -83. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between BGMS and HYFM?
These companies operate in different sectors (BGMS (Healthcare) and HYFM (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.